Literature DB >> 4969880

Human monoclonal gamma G-cryoglobulins with anti-gamma-globulin activity.

H M Grey, P F Kohler, W D Terry, E C Franklin.   

Abstract

Seven human gammaG-myeloma proteins which were also cryoglobulins were studied with respect to their reactivity with gammaG-globulins as well as with regard to their antigenic classification within the gammaG-heavy chain subclasses. Five of the seven cryoglobulins studied were positive in at least two of the three tests used to assay for anti-gamma-globulin activity. One protein was only weakly positive in one test system and another was negative in all test systems. The structures which were recognized by the cryoglobulins were localized to the Fc-fragment. Only primate gammaG-globulins contained these antigenic determinants and in some cases the cryoglobulin appeared to show specificity for one human heavy chain subclass over the others. Antigenic analysis revealed that four of the five cryoglobulins with definite antibody activity belonged to the gammaG3-subclass, the fifth belonged to the gammaG1-subclass. The two cryoglobulins which reacted only weakly or failed to combine with gammaG-globulins were both of the gammaG1-subclass. These findings taken together with the localization of the combining site to the Fab-fragment suggests that many of these cryoglobulins may represent antibodies to gammaG-globulin, and that the cryoprecipitate in these cases represents antigen-antibody complexes of such a nature that they precipitate only in the cold.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4969880      PMCID: PMC297348          DOI: 10.1172/JCI105878

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  AGGLUTINATION OF STORED ERYTHROCYTES BY A HUMAN SERUM. CHARACTERIZATION OF THE SERUM FACTOR AND ERYTHROCYTE CHANGES.

Authors:  F L OZER; H CHAPLIN
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

2.  Systemic lupus erythematosus. Cryoprecipitation of sera.

Authors:  C L CHRISTIAN; W B HATFIELD; P H CHASE
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

3.  Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties.

Authors:  J KRITZMAN; H G KUNKEL; J MCCARTHY; R C MELLORS
Journal:  J Lab Clin Med       Date:  1961-06

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Characterization of the gamma-globulin complexes present in certain sera having high titers of anti-gamma-globulin activity.

Authors:  R E Schrohenloher
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

6.  Cryoglobulinemia--a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability.

Authors:  M Meltzer; E C Franklin
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

7.  Exclusive occurrence of K chains in isolated cold haemagglutinins.

Authors:  M Harboe; R van Furth; H Schubothe; K Lind; R S Evans
Journal:  Scand J Haematol       Date:  1965

8.  SUBCLASSES OF HUMAN GAMMA-2-GLOBULIN BASED ON DIFFERENCES IN THE HEAVY POLYPEPTIDE CHAINS.

Authors:  W D TERRY; J L FAHEY
Journal:  Science       Date:  1964-10-16       Impact factor: 47.728

9.  Physical properties of the red cell agglutinins in acquired hemolytic anemia.

Authors:  H H FUDENBERG; H G KUNKEL
Journal:  J Exp Med       Date:  1957-11-01       Impact factor: 14.307

10.  Antihapten antibody specificity and L chain type.

Authors:  V Nussenzweig; B Benacerraf
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  25 in total

Review 1.  An experimental model of cryoglobulin-associated vasculitis in mice.

Authors:  Y Pastore; F Lajaunias; A Kuroki; T Moll; S Kikuchi; S Izui
Journal:  Springer Semin Immunopathol       Date:  2001

2.  Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.

Authors:  L Reininger; T Berney; T Shibata; F Spertini; R Merino; S Izui
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  Rheumatoid factors in mice bearing the lpr or gld mutation. Selective production of rheumatoid factor cryoglobulins in MRL/MPJ-lpr/lpr mice.

Authors:  T Shibata; T Berney; F Spertini; S Izui
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

4.  Sialylation determines the nephritogenicity of IgG3 cryoglobulins.

Authors:  Masako Otani; Aki Kuroki; Shuichi Kikuchi; Masao Kihara; Junichiro Nakata; Kiyoaki Ito; Jun-ichi Furukawa; Yasuro Shinohara; Shozo Izui
Journal:  J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 10.121

5.  Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

Authors:  M Coffey; J Hassan; C Feighery; M Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

6.  [Bence-Jones-plasmocytoma and cryoproteinemic purpura with intravascular precipitation of immunoglobulin G (author's transl)].

Authors:  F Weidner
Journal:  Arch Dermatol Forsch       Date:  1973

7.  [Paraproteins as the product of clonal immune proliferation--a contribution to the immunology and oncology of monoclonal proteins (author's transl)].

Authors:  O Wetter
Journal:  Klin Wochenschr       Date:  1973-09-15

8.  Anit-immunoglobulins in multiple myeloma.

Authors:  N I Abdou; N L Abdou
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

9.  IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases.

Authors:  S Izui; T Berney; T Shibata; T Fulpius
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

10.  The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis.

Authors:  R M Pope; D C Teller; M Mannik
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.